| Product Name | Erdafitinib |
| CAS | 1346242-81-6 |
| MF | C25H30N6O2 |
| MW | 446.54 |
| Packaging | 1kg/bag, 20kg/drum |
| Application | Edatinib is a kinase inhibitor targeting FGFR, used to treat adult patients with locally advanced or metastatic urothelial carcinoma who experience disease progression during or after platinum based chemotherapy. Patients with FGFR3 or FGFR2 gene mutations, including those who have received neoadjuvant or adjuvant platinum based chemotherapy for 12 months. |
| Storage | Keep in dark place,Sealed in dry,Room Temperature. |